Stewart-Jackson Pharmacal

With products in the respiratory, urology, and cardiovascular therapeutic categories, SJP actively seeks to commercialize new products via acquisition, in-licensing and new drug approvals. With 20 sales representatives and coverage in 11 states, SJP continues to build on its 30 plus year heritage as it cultivates a premier sales and marketing organization. SJP is currently well-positioned to launch its strategic growth objectives through territory expansion and product development.